BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help

Documents 1-21 out of 21 found
  Current Search:  natrecor: 202, nesiritide: 43, recombinant: 40084  

100%
PDF
Approved Products_2004.xls
Number A pproval Date Trade Name Generic/ Chemical name Indication Company 1 Oct- 82 Humulin Human Insulin Type I Diabetes Lilly / Genentech 2 Oct- 85 Protro pin Human Growth Hormone Hypoptuitary dwarfism Genentech 3 Jun- 86 Intron A Interferon Al pha 2B Hairy Cell Leukemia Schering Plough / Biogen 4 Jun- 86 OKT- 3 Anti CD3 Mab Acute Trans plant Rejection JNJ / OrthoBiotech 5 Jun- 86...

author: Reijer
Matching: natrecor nesiritide recombinant Find similar documents More document info

100%
HTML
Database N
N - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products.
Nabi-HB® Intravenous (3405) Nabumetone Q (1919) nAChR Agonist!
See Amerge® (1869) Nasal Calcitonin (1988) Natalizumab.
Matching: natrecor nesiritide recombinant Find similar documents More document info
100%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
1/35 28, ETHINYL ESTRADIOL NABUMETONE, NABUMETONE NADOLOL, NADOLOL NAFAZAIR, NAPHAZOLINE HYDROCHLORIDE NAFCILLIN SODIUM, NAFCILLIN SODIUM NAFTIN, NAFTIFINE HYDROCHLORIDE NALBUPHINE HCL, NALBUPHINE HYDROCHLORIDE NALBUPHINE, NALBUPHINE HYDROCHLORIDE NALFON 200, FENOPROFEN CALCIUM NALFON, FENOPROFEN CALCIUM NALIDIXIC ACID, NALIDIXIC ACID APPENDIX A PRODUCT NAME INDEX NALLPEN IN PLASTIC...

Matching: natrecor nesiritide recombinant Find similar documents More document info
100%
HTML
Prescription and OTC Drug Product List 8/2001
ACTHAR GEL -D- BC + AVENTIS 40 UNITS/ML N08372 006 FEB 06, 1956 AUG CAHN -D- BC + 80 UNITS/ML N08372 008 FEB 06, 1956 AUG CAHN -A- BC + QUESTCOR PHARMS 40 UNITS/ML N08372 006 FEB 06, 1956 AUG CAHN -A- BC + 80 UNITS/ML N08372 008 FEB 06, 1956 AUG CAHN DELAVIRDINE MESYLATE TABLET; ORAL RESCRIPTOR -D- + AGOURON 100MG N20705 001 APR 04, 1997 AUG CRLD -A- 100MG N20705 001 APR 04, 1997 AUG...
Matching: natrecor nesiritide recombinant Find similar documents More document info
83%
HTML
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Matching: natrecor nesiritide Find similar documents More document info
83%
HTML
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Matching: natrecor nesiritide Find similar documents More document info
83%
HTML
Nesiritide for acute heart failure - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Nesiritide for acute heart failure - [Medication] - Quest Diagnostics Patient Health Library Nesiritide for acute heart failure - [Medication] - Quest Diagnostics Patient Health Library cardiac failure, CHF, Congestive heart failure, Congestive...
Matching: natrecor nesiritide Find similar documents More document info
83%
HTML
Advances in the Treatment of Cardiovascular Diseases
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
author: BioPortfolio - Knowledge Management, Market Analysis and Market Research
Matching: natrecor nesiritide Find similar documents More document info
83%
HTML
Advances in the Treatment of Cardiovascular Diseases
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
author: BioPortfolio - Knowledge Management, Market Analysis and Market Research
Matching: natrecor nesiritide Find similar documents More document info
83%
PDF
Approved Products_2004.xls page 4


author: Reijer
Matching: natrecor nesiritide Find similar documents More document info

83%
HTML
Scios - Company
launch of Natrecor ® (nesiritide), the first new approved treatment for acute heart failure in more than a decade.
Scios Inc., a member of the Johnson & Johnson Family of Companies, is a headquartered in Fremont, California, and markets two products for the treatment of heart disease: Natrecor ® (nesiritide), for the treatment of acutely decompensated...
Matching: natrecor nesiritide Find similar documents More document info
83%
HTML
20-920_Natrecor.htm
Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Natrecor (Nesiritide) Injection Company:--Scios Inc
Application No.:--20-920 Approval Date:-8/10/2001 - Approval Letter(s) - Printed Labeling - Medical Review(s) Part 1 - Part 5 - Part 9 - Part 2 - Part 6 - Part 10 - Part 3 - Part 7 - Part 11 - Part 4 - Part 8 -...
author: Paul Stauffer
Matching: natrecor nesiritide Find similar documents More document info
83%
HTML
CDER Report to the Nation: 2001
New molecular entities Almotriptan malate (Axert) Bimatoprost (Lumigan) Bosentan (Tracleer) Caspofungin acetate (Cancidas) Cefditoren pivoxil (Spectracef) Desloratadine (Clarinex) Drospirenone/ethinyl estradiol (Yasmin) Dutasteride (Dutasteride) Ertapenem sodium (Invanz) Etonogestrel/ethinyl estradiol (NuvaRing) Fondaparinux sodium (Arixtra) Formoterol fumarate (Foradil Aerolizer)...
author: OLIVERN
Matching: natrecor nesiritide Find similar documents More document info
83%
HTML
NDA Approvals for Calendar Year 2001
Braun 5 S 21-Feb-01 21-235 Prozac Weekly Fluoxetine Hydrochloride Eli Lilly 3 S 26-Feb-01 21-169 Reminyl Galantamine Hydrobromide Janssen Research 1 S 28-Feb-01 21-082 Tavist Allergy/Sinus/Headache Acetaminophen/Clemastine Fumarate/Pseudoephedrine Hydrochloride Novartis 4 S 01-Mar-01 21-257 Travatan Travoprost Alcon 1 P 16-Mar-01 21-262 Alphagan P Brimonidine Tartrate Allergan 3 S 16...
author: Brenda Harmon
Matching: natrecor nesiritide Find similar documents More document info
83%
HTML
FDA Drug Approvals List August 2001
- Drug Approvals for August 2001 Definitions and Notes Original New Drug Applications Original Application #: 021222 Approval Date: 29-AUG-01 Trade Name: SPECTRACEF Chemical Type: 1 Therapeutic Potential: S Dosage Form: TABLET Applicant: TAP PHARMACEUTICAL PRODUCTS INC Active Ingredient(s): CEFDITOREN PIVOXIL OTC/RX Status: RX Indication(s): For the treatment of acute bacterial...
Matching: natrecor nesiritide Find similar documents More document info
83%
PDF
H:\PM Folder\NDA ltrs\20920AP.doc
Nesiritide has a molecular weight of 3464 g/ mol and an empirical formula of C143H244N50O42S4
Nesiritide has the same 32 amino acid sequence as the endogenous peptide, which is produced by the ventricular myocardium
Nesiritide has been shown to relax rhBNP Page 2 isolated human arterial and venous tissue preparations that were precontracted with either...

author: Quynh Nguyen
Matching: natrecor nesiritide Find similar documents More document info

83%
PDF
H:\PM Folder\NDA ltrs\20920AP.doc page 1


author: Quynh Nguyen
Matching: natrecor nesiritide Find similar documents More document info

55%
HTML
BioPortfolio Client Press Releases Site Map
Where Science and Art Meet Images Generated by Auto-Montage Shown at Prestigious Art Exhibition BMD announces new ISO 9001 certification Affymetrix at ESHG meeting - preview of new product Synbiosis Names Don Whitley Dealer of the Year OXFORD BIOMEDICA - COMPANY UPDATE AT AGM Wong’s BioTech Stock Report - Bumps In the Road Genentech Wong’s BioTech Stock Report - outlook on...
Matching: natrecor recombinant Find similar documents More document info
55%
HTML
Approved Biotechnology Drugs, 2002
- Treatment of severe combined immunodeficiency disease (SCID) - Mar 1990 Advate (Recombinant antihemophilic factor produced without any added human or animal plasma proteins and albumin) - Baxter Healthcare Corp
- Attention deficit hyperactivity disorder - Nov 2001 Follistim™ (follitropin beta) - Organon (unit of Akzo Nobel) - Recombinant follicle-stimulating...
Matching: natrecor recombinant Find similar documents More document info
55%
PDF
48759231.pdf
Placebo, On A Background Of Standard Care Including Aspirin, In Maintaining The Patency Of Lower Limb Aterieres After Angioplasty Endothelial No- Synthase ASnd Cerebral Circulation Cerebral Vascular Biology Program Project Grant Vascular Mechanism In Atherogenesis- Program Project Grant Pathophysiological Rose Of Adipose Angiotensinogen In Obesity (Fellowship- Kamal Rahmouni) Fetal...

author: Oracle Reports
Matching: natrecor recombinant Find similar documents More document info

55%
PDF
http://www.phrma.org/newmedicines/resources/bio00.pdf page 20


Matching: natrecor recombinant Find similar documents More document info


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.